Benzinga | Nov 15, 2021 04:40PM EST

TransCode Therapeutics Q3 EPS $(0.20) Up From $(0.30) YoY

TransCode Therapeutics (NASDAQ:RNAZ) reported quarterly losses of $(0.20) per share. This is a 33.33 percent increase over losses of $(0.30) per share from the same period last year.